大腸癌におけるsyndecan-1 発現低下はTNM分類および予後と強く相関する (Preliminary Note)

作者: 高後 裕 , 藤谷 幹浩 , 斉藤 裕輔 , 蘆田 知史 , 小原 剛

DOI: 10.11241/JSMTMR.16.21

关键词: Medicine

摘要:

参考文章(6)
Suzanne A. Eccles, Heparanase: breaking down barriers in tumors. Nature Medicine. ,vol. 5, pp. 735- 736 ,(1999) , 10.1038/10455
Akinori Matsumoto, Minoru Ono, Yoshinori Fujimoto, Richard L. Gallo, Merton Bernfield, Yutaka Kohgo, Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. International Journal of Cancer. ,vol. 74, pp. 482- 491 ,(1997) , 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#
Pierre Michel, Veronique Merle, Anne Chiron, Philippe Ducrotte, Bernard Paillot, Philippe Hecketsweiler, Pierre Czernichow, Raymond Colin, Postoperative management of stage II/III colon cancer: A decision analysis Gastroenterology. ,vol. 117, pp. 784- 793 ,(1999) , 10.1016/S0016-5085(99)70335-5
Hiroki Tanabe, Kinichi Yokota, Yutaka Kohgo, Localization of syndecan-1 in human gastric mucosa associated with ulceration. The Journal of Pathology. ,vol. 187, pp. 338- 344 ,(1999) , 10.1002/(SICI)1096-9896(199902)187:3<338::AID-PATH229>3.0.CO;2-#
Norbert Perrimon, Merton Bernfield, Specificities of heparan sulphate proteoglycans in developmental processes Nature. ,vol. 404, pp. 725- 728 ,(2000) , 10.1038/35008000